Aprea Therapeutics APRE
NASDAQ APRE
$0.77 +0.00 (+0.13%)
As of: Sep 30, 2026 · 10:24 AM EDT

Aprea Therapeutics (APRE) Non-Current Assets (2018 - 2026)

Updated

Aprea Therapeutics (APRE) recorded Non-Current Assets of $376,810 in Q2 2026, down 1.5% from $382,500 a year earlier but up 2.7% from the prior quarter.

Analysis

Aprea Therapeutics (APRE) Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, Aprea Therapeutics reported Non-Current Assets of $372,155, down 7.7% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $403,354 in FY2024 (+212.5%), $129,079 in FY2023, $2,321 in FY2022 (-99.0%) and $239,053 in FY2021 (-38.5%).
  • Quarterly Non-Current Assets has ranged from $1,912 in Q1 2023 to $410,149 in Q3 2024 over the past five years.
  • On a year-over-year basis, Non-Current Assets has declined for five consecutive quarters, with growth averaging 75.5% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 866.9% in Q2 2024, against a decline of 99.3% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $366,947 (Q1 2026), $372,155 (Q4 2025) and $377,328 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Aprea Therapeutics 40.11 Mn 40.11 Mn - 376,810.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 376,810.00
Mar 31, 2026 366,947.00
Dec 31, 2025 372,155.00
Sep 30, 2025 377,328.00
Jun 30, 2025 382,500.00
Mar 31, 2025 387,673.00
Dec 31, 2024 403,354.00
Sep 30, 2024 410,149.00
Jun 30, 2024 404,801.00
Mar 31, 2024 131,169.00
Dec 31, 2023 129,079.00
Sep 30, 2023 126,647.00
Jun 30, 2023 41,867.00
Mar 31, 2023 1,912.00
Dec 31, 2022 2,321.00
Sep 30, 2022 148,125.00
Jun 30, 2022 220,584.00
Mar 31, 2022 292,139.00
Dec 31, 2021 239,053.00
Sep 30, 2021 305,527.00
API Access

Aprea Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=APRE&period=max&api_key=YOUR_API_KEY